Literature DB >> 28150851

Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.

Anna K Stuck, David Spirk, Jil Schaudt, Nils Kucher1.   

Abstract

Although the use of thromboprophylaxis is recommended for acutely ill medical patients at increased risk of venous thromboembolism (VTE), it remains unclear which risk assessment model (RAM) should be routinely used to identify at-risk patients requiring thromboprophylaxis. We therefore aimed to describe existing RAMs, and to compare these tools in terms of validity and applicability for clinical decision-making. We performed a comprehensive systematic search in MEDLINE from the date of initiation until May 2016 for studies in acutely ill medical patients investigating validity of RAMs for VTE. Two reviewers independently screened the title, abstract, and full text, and evaluated the characteristics of studies, and the composition, evidence of validation, and results on validity of the RAMs. We included 11 studies assessing eight RAMs: 4-Element RAM, Caprini RAM, a full logistic model, Geneva risk score, IMPROVE-RAM, Kucher Model, a "Multivariable Model", and Padua Prediction Score. The 4-Element RAM, IMPROVE-RAM, Multivariable Model, and full logistic model had derivation by identifying factors with predictive power. The other four RAMs were empirically generated based on consensus guidelines, published data, and clinical expertise. The Kucher Model, the Padua Prediction Score, the Geneva Risk Score and the IMPROVE-RAM underwent multicenter external validation. The Kucher Model, the Padua Prediction Score, and the Geneva Risk Score improved rates of thromboprophylaxis or clinical outcomes. In conclusion, existing RAMs to evaluate the need of thromboprophylaxis in acutely ill medical patients are difficult to compare and none fulfills the criteria of an ideal RAM. Nevertheless, the adequacy of thromboprophylaxis may be improved by implementing one of the validated RAMs.

Entities:  

Keywords:  Thrombosis; clinical prediction rule; inpatients; prophylaxis; review; systematic

Mesh:

Substances:

Year:  2017        PMID: 28150851     DOI: 10.1160/TH16-08-0631

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  25 in total

1.  Poor Adherence to Risk Stratification Guidelines Results in Overuse of Venous Thromboembolism Prophylaxis in Hospitalized Older Adults.

Authors:  Juliessa M Pavon; Richard J Sloane; Carl F Pieper; Cathleen S Colón-Emeric; Harvey J Cohen; David Gallagher; Miriam C Morey; Midori McCarty; Thomas L Ortel; Susan N Hastings
Journal:  J Hosp Med       Date:  2018-02-06       Impact factor: 2.960

Review 2.  Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients? Yes.

Authors:  Walter Ageno
Journal:  Intern Emerg Med       Date:  2017-08-14       Impact factor: 3.397

3.  Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue.

Authors:  Antonella Tufano; Giovanni Di Minno
Journal:  Intern Emerg Med       Date:  2018-03-14       Impact factor: 3.397

4.  Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews.

Authors:  Andrea J Darzi; Allen B Repp; Frederick A Spencer; Rami Z Morsi; Rana Charide; Itziar Etxeandia-Ikobaltzeta; Kenneth A Bauer; Allison E Burnett; Mary Cushman; Francesco Dentali; Susan R Kahn; Suely M Rezende; Neil A Zakai; Arnav Agarwal; Samer G Karam; Tamara Lotfi; Wojtek Wiercioch; Reem Waziry; Alfonso Iorio; Elie A Akl; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-10-13

5.  Improved utilisation of venous thromboembolism prophylaxis in renal-impaired patients following a clinical pharmacist intervention.

Authors:  Naemeh Nikvarz; Zahra Seyedi
Journal:  Eur J Hosp Pharm       Date:  2019-12-11

6.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

Authors:  Holger J Schünemann; Mary Cushman; Allison E Burnett; Susan R Kahn; Jan Beyer-Westendorf; Frederick A Spencer; Suely M Rezende; Neil A Zakai; Kenneth A Bauer; Francesco Dentali; Jill Lansing; Sara Balduzzi; Andrea Darzi; Gian Paolo Morgano; Ignacio Neumann; Robby Nieuwlaat; Juan J Yepes-Nuñez; Yuan Zhang; Wojtek Wiercioch
Journal:  Blood Adv       Date:  2018-11-27

7.  External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.

Authors:  Alex C Spyropoulos; Joanna B Eldredge; Lalitha N Anand; Meng Zhang; Michael Qiu; Soheila Nourabadi; David J Rosenberg
Journal:  Oncologist       Date:  2020-02-04

8.  Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment.

Authors:  Andrea J Darzi; Samer G Karam; Frederick A Spencer; Alex C Spyropoulos; Lawrence Mbuagbaw; Scott C Woller; Neil A Zakai; Michael B Streiff; Michael K Gould; Mary Cushman; Rana Charide; Itziar Etxeandia-Ikobaltzeta; Federico Germini; Marta Rigoni; Arnav Agarwal; Rami Z Morsi; Elie A Akl; Alfonso Iorio; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-06-23

Review 9.  Bleeding risk assessment for venous thromboembolism prophylaxis.

Authors:  Maria Chiara Chindamo; Marcos Arêas Marques
Journal:  J Vasc Bras       Date:  2021-04-28

Review 10.  Thromboembolic Complications of SARS-CoV-2 and Metabolic Derangements: Suggestions from Clinical Practice Evidence to Causative Agents.

Authors:  Francesco Nappi; Adelaide Iervolino; Sanjeet Singh Avtaar Singh
Journal:  Metabolites       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.